The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Abstract
The selective estrogen-receptor modulators, or SERMs, chemically diverse nonsteroid compounds, have tertiary structures that permit binding to the estrogen receptor. These compounds have either selective agonist or antagonist effects, depending on the target tissue. This article reviews current information concerning the molecular basis of SERM action and the tissue-selective agonist–antagonist effects of this class of medication. The article also offers a perspective on the therapeutic uses of SERMs and compares the SERMs with estrogen and nonestrogen alternatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Self-citationDelmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Reginster, J.-Y., Minne, H. W., Sorensen, O. H., Hooper, M., Roux, C., Brandi, M. L., Lund, B., Ethgen, D., Pack, S., Roumagnac, I., et al. (2000) · Osteoporosis International · doi:10.1007/s001980050010 · Cited by 1,580
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Molecular Determinants for the Tissue Specificity of SERMs
Shang, Y., & Brown, M. (2002) · Science · doi:10.1126/science.1068537 · Cited by 1,146
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Estrogen and the Risk of Breast Cancer
Clemons, M., & Goss, P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440407 · Cited by 1,096
Hall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Production and Actions of Estrogens
Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmra000471 · Cited by 1,062
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Powles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Bonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Hortobagyi, G. N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391407 · Cited by 781
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal Women
Walsh, B. W. (1998) · JAMA · doi:10.1001/jama.279.18.1445 · Cited by 692
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Powles, T. J., Hickish, T., Kanis, J. A., Tidy, A., & Ashley, S. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.78 · Cited by 646
Estrogen Actions in the Central Nervous System
McEwen, B. S. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.279 · Cited by 640
Fisher, B., Dignam, J., Bryant, J., & Wolmark, N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.684 · Cited by 635
Treatment of Postmenopausal Osteoporosis
Eastell, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381107 · Cited by 615
Miller, V. T., LaRosa, J. C., Barnabei, V. M., Kessler, C. M., Levin, G., Smith-Roth, A., Griffin, M. E., Stoy, D. B., Bush, T. L., Zacur, H. A., et al. (1995) · JAMA · doi:10.1001/jama.273.3.199 · Cited by 601
Barrett-Connor, E., Grady, D., Sashegyi, A., Anderson, P. W., Cox, D. A., Hoszowski, K., Rautaharju, P., Harper, K. D., & for the MORE Investigators (2002) · JAMA · doi:10.1001/jama.287.7.847 · Cited by 577
Combinatorial Roles of the Nuclear Receptor Corepressor in Transcription and Development
Jepsen, K., Hermanson, O., Onami, T. M., Gleiberman, A. S., Lunyak, V., McEvilly, R. J., Kurokawa, R., Kumar, V., Liu, F., Seto, E., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00064-7 · Cited by 503
Lindberg, M. K., Movérare, S., Skrtic, S., Gao, H., Dahlman-Wright, K., Gustafsson, J.-A., & Ohlsson, C. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0206 · Cited by 479
Estrogen receptor beta--a new dimension in estrogen mechanism of action
Gustafsson, J. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630379 · Cited by 423
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000058687.18516.14 · Cited by 390
Effects of Tamoxifen on Cardiovascular Risk Factors in Postmenopausal Women
Love, R. R., Wiebe, D. A., Newcomb, P. A., Cameron, L., Leventhal, H., Jordan, V. C., Feyzi, J., & DeMets, D. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-860 · Cited by 374
Peptide Antagonists of the Human Estrogen Receptor
Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C.-Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., & McDonnell, D. P. (1999) · Science · doi:10.1126/science.285.5428.744 · Cited by 373
Postmenopausal hormones and incontinence: the heart and Estrogen/Progestin Replacement Study
Grady, D. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01115-7 · Cited by 364
Estrogen receptor β acts as a dominant regulator of estrogen signaling
Pettersson, K., Delaunay, F., & Gustafsson, J.-Å. (2000) · Oncogene · doi:10.1038/sj.onc.1203828 · Cited by 362
Structural Insights into the Mode of Action of a Pure Antiestrogen
Pike, A. C. W., Brzozowski, A. M., Walton, J., Hubbard, R. E., Thorsell, A.-G., Li, Y.-L., Gustafsson, J.-Å., & Carlquist, M. (2001) · Structure · doi:10.1016/s0969-2126(01)00568-8 · Cited by 347
Use of Hormone Replacement Therapy by Postmenopausal Women in the United States
Keating, N. L., Cleary, P. D., Rossi, A. S., Zaslavsky, A. M., & Ayanian, J. Z. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00002 · Cited by 329
Walsh, B. W., Paul, S., Wild, R. A., Dean, R. A., Tracy, R. P., Cox, D. A., & Anderson, P. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6326 · Cited by 326
Effects of anti-estrogens on bone in castrated and intact female rats
Jordan, V. C., Phelps, E., & Lindgren, J. U. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01806132 · Cited by 324
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M. A., & for the HERS Research Group (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 303
Estrogen Receptors α and β Are Differentially Expressed in Developing Human Bone1
Bord, S., Horner, A., Beavan, S., & Compston, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7513 · Cited by 300
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer
Goss, P. E., & Strasser, K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.881 · Cited by 298
Riggs, B. L., & Melton, L. J. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.11 · Cited by 248
Self-citationTreatment of Established Postmenopausal Osteoporosis with Raloxifene: A Randomized Trial
Lufkin, E. G., Whitaker, M. D., Nickelsen, T., Argueta, R., Caplan, R. H., Knickerbocker, R. K., & Riggs, B. L. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1747 · Cited by 237
Self-citationHall, J. M. (1999) · Endocrinology · doi:10.1210/en.140.12.5566 · Cited by 226
TURNER, R. T., WAKLEY, G. K., HANNON, K. S., & BELL, N. H. (1988) · Endocrinology · doi:10.1210/endo-122-3-1146 · Cited by 224
Hayes, D. F., Van Zyl, J. A., Hacking, A., Goedhals, L., Bezwoda, W. R., Mailliard, J. A., Jones, S. E., Vogel, C. L., Berris, R. F., & Shemano, I. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2556 · Cited by 216
Johnston, C. C., Bjarnason, N. H., Cohen, F. J., Shah, A., Lindsay, R., Mitlak, B. H., Huster, W., Draper, M. W., Harper, K. D., Heath, H., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3444 · Cited by 211
Heshmati, H. M., Khosla, S., Robins, S. P., O'Fallon, W. M., Melton, L. J., & Riggs, B. L. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.172 · Cited by 207
Self-citationCognitive Function in Postmenopausal Women Treated with Raloxifene
Yaffe, K., Krueger, K., Sarkar, S., Grady, D., Barrett-Connor, E., Cox, D. A., & Nickelsen, T. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441604 · Cited by 203
Winer, E. P., Hudis, C., Burstein, H. J., Chlebowski, R. T., Ingle, J. N., Edge, S. B., Mamounas, E. P., Gralow, J., Goldstein, L. J., Pritchard, K. I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.020 · Cited by 200
Effect of Tamoxifen on Lumbar Spine Bone Mineral Density in Postmenopausal Women After 5 Years
Love, R. R. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.22.2585 · Cited by 199
Fogelman, I., Ribot, C., Smith, R., Ethgen, D., Sod, E., & Reginster for the bmd-mn Study Grou, J.-Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6603 · Cited by 198
Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A., Lipkus, I., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197
Cognitive Function in Postmenopausal Women Treated With Raloxifene
Yaffe, K., Krueger, K., Sarkar, S., Grady, D., Barrett-Connor, E., Cox, D. A., & Nickelsen, T. (2001) · Obstetrical and Gynecological Survey · doi:10.1097/00006254-200109000-00018 · Cited by 197
Effects of Tamoxifen on Spinal Bone Density in Women With Breast Cancer
Turken, S., Siris, E., Seldin, D., Flaster, E., Hyman, G., & Lindsay, R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1086 · Cited by 194
Selective estrogen receptor modulation: a personal perspective.
Jordan, V. C. (2001) · PubMed · Cited by 174
Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys1
Clarkson, T. B., Anthony, M. S., & Jerome, C. P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4617 · Cited by 170
Design and methods of the Raloxifene Use for The Heart (RUTH) study
Mosca, L., Barrett-Connor, E., Wenger, N. K., Collins, P., Grady, D., Kornitzer, M., Moscarelli, E., Paul, S., Wright, T. J., Helterbrand, J. D., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01685-x · Cited by 166
Breast cancer and hormone replacement therapy.
LaCroix, A. Z., & Burke, W. (1990) · PubMed · Cited by 155
The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women
Grey, A. B., Stapleton, J. P., Evans, M. C., Tatnell, M. A., Ames, R. W., & Reid, I. R. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80251-4 · Cited by 154
Effects of estrogen replacement on the progression of coronary artery atherosclerosis
Herrington, D. M., Beboussin, D. M., & Brosnihan, K. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(00)00172-0 · Cited by 152
Coronary heart disease: an older woman's major health risk
WENGER, N. K. (1997) · BMJ · doi:10.1136/bmj.315.7115.1085 · Cited by 148
Saarto, T., BLOMQVIST, C. P., Ehnholm, C., Taskinen, M., & Elomaa, I. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.429 · Cited by 145
Walsh, B. W. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.214 · Cited by 143
Marttunen, M. B., Hietanen, P. S., Tiitinen, A. E., & Ylikorkala, O. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4688 · Cited by 127
Wu, X., Glinn, M. A., Ostrowski, N. L., Su, Y., Ni, B., Cole, H. W., Bryant, H. U., & Paul, S. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02062-4 · Cited by 106
Estrogen Receptors and Are Differentially Expressed in Developing Human Bone
Bord, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2309 · Cited by 101
Pyrhönen, S. O., Valavaara, R., Modig, H. G., Pawlicki, M., Pieńkowski, T., Gundersen, S., Bauer, J., Westman, G., Lundgren, S., Blanco, G., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.375 · Cited by 96
Update on endocrine therapy for breast cancer.
Buzdar, A. U., & Hortobágyi, G. N. (1998) · PubMed · Cited by 91
Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen
Kristensen, B., Ejlertsen, B., Mouridsen, H. T., Andersen, K. W., & Lauritzen, J. B. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806160 · Cited by 79
Hormones and Heart Disease in Women: Heart and Estrogen/Progestin Replacement Study in Perspective
Barrett-Connor, E. L., & Stuenkel, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5667 · Cited by 69
Breast cancer and hormone replacement therapy
LaCroix, A. Z., & Burke, W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)22041-6 · Cited by 43
Earl, H., Gray, R. G., Kerr, D. J., et al. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(97)80067-2 · Cited by 31
Pavo, I. J., László, F., Morschl, É., Nemcsik, J., Berkó, A. M., Cox, D. A., & László, F. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00865-7 · Cited by 26
Cited by
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Awareness and current knowledge of breast cancer
Akram, M., Iqbal, M., Daniyal, M., & Khan, A. U. (2017) · Biological Research · doi:10.1186/s40659-017-0140-9 · Cited by 1,406
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Kumar, K., Taylor, R. S., Jacques, L., Eldabe, S., Meglio, M., Molet, J., Thomson, S., O’Callaghan, J., Eisenberg, E., Milbouw, G., et al. (2007) · Pain · doi:10.1016/j.pain.2007.07.028 · Cited by 1,184
Osteoporosis treatment: recent developments and ongoing challenges
Khosla, S., & Hofbauer, L. C. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30188-2 · Cited by 1,019
Metadata
- Authors
- Riggs, B. L., & Hartmann, L. C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-02-13
- Volume
- 348
- Issue
- 7
- Pages
- 618-629
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1971909806
- Cited by
- 968
- References
- 100
- FWCI
- 33.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.